Suspension of trading
Oncternal Therapeutics, Inc. Share Price
Stocks
ONCT
US68236P2065
Biotechnology & Medical Research
|
Delayed
Nasdaq
02:30:00 03/12/2024 am IST
|
5-day change | 1st Jan Change | ||
| 0.5266 USD | -24.11% |
|
-.--% | - |
| 01/25/01 | Oncternal Therapeutics, Inc. Appoints Craig R. Jalbert as CEO | CI |
| 01/25/01 | Oncternal Therapeutics, Inc. Announces Management Changes | CI |
| Market Cap | 15.59L 13.44L 12.65L 11.52L 21.66L 15Cr 21.78L 1.5Cr 58.19L 7.52Cr 58.52L 57.25L 25Cr | P/E 2022 |
-1.19x | P/E 2023 | -0.8x |
|---|---|---|---|---|---|
| Enterprise Value | -3.24Cr -2.79Cr -2.63Cr -2.39Cr -4.5Cr -307.29Cr -4.53Cr -31Cr -12Cr -156.31Cr -12Cr -12Cr -518.31Cr | EV / Sales 2022 |
-4.9x | EV / Sales 2023 | -2.95x |
| Free-Float |
90.77% | Yield 2022 * |
-
| Yield 2023 | - |
| 1 day | -24.11% |
| 3 years | 0.53 |  | 13.14 |
| 5 years | 0.53 | | 92.6 |
| 10 years | 0.53 | | 211.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Vincent
DFI | Director of Finance/CFO | 63 | 01/04/2017 |
Yisrael Katz
CTO | Chief Tech/Sci/R&D Officer | - | 01/07/2023 |
Rajesh Krishnan
CTO | Chief Tech/Sci/R&D Officer | 53 | - |
| Director | Title | Age | Since |
|---|---|---|---|
David Hale
CHM | Chairman | 77 | 01/12/2018 |
Dan Kisner
BRD | Director/Board Member | 79 | 07/06/2019 |
William LaRue
BRD | Director/Board Member | 75 | 01/12/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 20/06/24 | Free | Director | 2,200 | 0.0743% | ||
| 20/06/24 | Free | Director | 2,200 | 0.0743% | ||
| 20/06/24 | Free | Director | 2,200 | 0.0743% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -24.11% | -.--% | -.--% | -91.22% | 15.59L | |
| +0.21% | -2.69% | +1.19% | +17.32% | 4.98TCr | |
| +1.30% | -1.60% | +426.18% | +493.44% | 4.41TCr | |
| -0.91% | -0.30% | +40.77% | +15.30% | 4.3TCr | |
| -0.42% | -4.74% | +7.98% | +71.62% | 4.09TCr | |
| -0.48% | -3.09% | +17.78% | +49.80% | 3.31TCr | |
| -1.34% | -4.70% | +23.63% | +113.96% | 1.66TCr | |
| -1.74% | +3.12% | - | - | 1.73TCr | |
| -1.35% | -3.40% | +10.13% | +26.34% | 1.46TCr | |
| -1.41% | -4.46% | +76.36% | +35.66% | 1.38TCr | |
| Average | -2.96% | -4.06% | +67.11% | +81.36% | 2.73TCr | |
| Weighted average by Cap. | -0.24% | -1.79% | +90.28% | +119.63% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 14.9L 12.85L 12.09L 11.01L 20.71L 14Cr 20.82L 1.43Cr 55.63L 7.19Cr 55.94L 54.73L 24Cr | 8L 7L 6L 6L 10.91L 7.45Cr 10.97L 75.3L 29.31L 3.79Cr 29.47L 28.83L 13Cr |
| Net income | -4.42Cr -3.81Cr -3.58Cr -3.27Cr -6.14Cr -419.2Cr -6.17Cr -42Cr -16Cr -213.24Cr -17Cr -16Cr -707.06Cr | -3.95Cr -3.41Cr -3.2Cr -2.92Cr -5.49Cr -374.68Cr -5.52Cr -38Cr -15Cr -190.59Cr -15Cr -15Cr -631.97Cr |
| Net Debt | -6.36Cr -5.49Cr -5.16Cr -4.7Cr -8.85Cr -603.95Cr -8.89Cr -61Cr -24Cr -307.22Cr -24Cr -23Cr -1.02TCr | -3.39Cr -2.93Cr -2.75Cr -2.51Cr -4.72Cr -322.08Cr -4.74Cr -33Cr -13Cr -163.84Cr -13Cr -12Cr -543.26Cr |
Employees
29
- Stock Market
- Stocks
- ONCT Stock
Select your edition
All financial news and data tailored to specific country editions
